Emergency Cold Chain Packaging for Temperature-Sensitive Biologic

A leading biotechnology company experienced a critical failure at their existing packaging partner, putting a temperature-sensitive biologic requiring 2-8°C storage and handling at immediate risk. The product was a high-value injectable biologic with strict cold chain requirements, and any gap in packaging capacity threatened patient supply across multiple markets.

The company needed emergency packaging capacity within 6 weeks — a timeline that would typically require months of qualification, validation, and regulatory preparation. Every day of delay represented potential supply disruption for patients depending on this therapy.

Meridan mobilized its Facility II cold chain infrastructure immediately, assembling a cross-functional team spanning quality, engineering, production, and project management. The team worked around the clock to execute an accelerated qualification program that compressed typical timelines without compromising quality or regulatory compliance.

Accelerated qualification protocols were developed and executed for the cold chain packaging process, including temperature mapping of storage and packaging areas, equipment qualification, and process validation. The validated cold chain packaging process was established to maintain the product’s 2-8°C requirements throughout the entire packaging operation.

Continuous temperature monitoring was implemented at every stage, from incoming material receipt through finished goods storage, with real-time alerting to ensure any deviation would be detected and addressed immediately.